
|Articles|June 1, 2004
- Volume 0 0
Exam
Advertisement
Articles in this issue
over 21 years ago
dual pathover 21 years ago
Managed Care Commentary:MCOs face new challengesover 21 years ago
Phytosterols may play role in atherosclerosisover 21 years ago
Dual pathway inhibition: Attacking cholesterol on two frontsover 21 years ago
Future Goals, Targets, and Treatments of DyslipidemiaNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
2
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
3
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5

















































































































































































































